Low-dose chloroquine is associated with favourable effects on lipoprotein metabolism without significant influence on insulin resistance.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.|National University Health System, Singapore.
L S
LS
Lee
Department of Endocrinology, Tan Tock Seng Hospital, Singapore.|Singapore Institute for Clinical Sciences, Singapore.|Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore.
M K
MK
Leow
Centre for Quantitative Medicine, Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore.|Singapore Clinical Research Institute, Singapore.
Y
Y
Xu
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.|National University Health System, Singapore.
A
A
Wilder-Smith
Centre for Quantitative Medicine, Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore.|Singapore Clinical Research Institute, Singapore.|Department of International Health, University of Tampere, Finland.
Y B
YB
Cheung
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.|National University Health System, Singapore.
N I
NI
Paton
D000328:Adult; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D002738:Chloroquine / Q000008:administration & dosage*; D002784:Cholesterol / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism*; D008297:Male; D024821:Metabolic Syndrome / Q000188:drug therapy / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D008074:Lipoproteins; D014280:Triglycerides; D002738:Chloroquine; D002784:Cholesterol